(Q44188013)

English

Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Alzheimer's disease

0 references

author name string

Takahiko Shimizu

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Hiroyuki Fukuda

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Shigeo Murayama

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Naoki Izumiyama

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Takuji Shirasawa

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Journal of Neuroscience Research

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

451-461

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Frequency of stages of Alzheimer-related lesions in different age categories: concurrences and cautions

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Identification of an isoaspartyl linkage formed upon deamidation of bovine calbindin D9k and structural characterization by 2D 1H NMR.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Modified-peptide inhibitors of amyloid beta-peptide polymerization

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Synthesis, aggregation, and neurotoxicity of the Alzheimer's Abeta1-42 amyloid peptide and its isoaspartyl isomers

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Racemization: its biological significance on neuropathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Molecular aging of tubulin: accumulation of isoaspartyl sites in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Translating cell biology into therapeutic advances in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Deamidation and isoaspartate formation in smeared tau in paired helical filaments. Unusual properties of the microtubule-binding domain of tau.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10350

21 January 2018

Identifiers

10.1002/JNR.10350

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44188013&oldid=2108358129"